At the end of last year, TherapeutAix published an article titled ‘The future R&D landscape in non-alcoholic steatohepatitis’ in Drug…
MassBio is holding a ‘State of Possible Conference’ for 2 days on the 27-28th March in Cambridge, Massachusetts. The event…
Darcey Black, Translational Director of TherapeutAix, will be speaking at the 18th Fraunhofer Seminar titled “Models of Lung Disease” on…
Since 2018 is quickly coming to an end, we look back at the past few months and reflect on all…
The availability of 2 approved medicines for the treatment of idiopathic pulmonary fibrosis (IPF) has stimulated an explosion in fibrosis…